OPTIMIZERX CORPORATION Reports 1.1% Decrease in Total Revenue for Quarter Ending June 30 2023
August 17, 2023
🌥️Earnings Overview
For the quarter ending June 30 2023, OPTIMIZERX CORPORATION ($NASDAQ:OPRX) reported total revenue of USD 13.8 million, a 1.1% decrease from the corresponding quarter in FY2022. Net income was USD -4.2 million, a further decline from the previous year’s reported figure of -3.9 million.
Analysis
GoodWhale has conducted an analysis of the wellbeing of OPTIMIZERX CORPORATION. Based on the Star Chart, OPTIMIZERX CORPORATION is classified as ‘rhino’ which refers to a company that has achieved moderate revenue or earnings growth. Such a company could be of interest to a wide variety of investors, ranging from growth investors to more value-oriented investors. In terms of its financial health, OPTIMIZERX CORPORATION has a high health score of 7/10 in relation to its cash flows and debt, indicating it is capable of sustaining future operations in times of crisis. Furthermore, OPTIMIZERX CORPORATION is strong in asset and growth and medium in profitability, though it is weak in dividend. As such, it may offer potential investors an opportunity for steady long-term growth. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Optimizerx Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 61.56 | -14.35 | -23.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Optimizerx Corporation. More…
| Operations | Investing | Financing |
| 3.81 | -54.32 | -27.08 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Optimizerx Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 121.32 | 5.51 | 6.96 |
Key Ratios Snapshot
Some of the financial key ratios for Optimizerx Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 28.9% | -22.9% | -26.9% |
| FCF Margin | ROE | ROA |
| 3.9% | -8.6% | -8.5% |
Peers
Its main competitors are Dialogue Health Technologies Inc, Phreesia Inc, and Sharecare Inc. All three companies offer similar services and products, but each has its own unique selling points.
– Dialogue Health Technologies Inc ($TSX:CARE)
The company’s market cap is 178.89M as of 2022 and its ROE is -16.56%. The company provides healthcare technology solutions that enable communication between patients and providers. The company’s products and services include electronic health records, patient portals, and telehealth solutions. The company’s products and services are used by healthcare providers, patients, and payers.
– Phreesia Inc ($NYSE:PHR)
Phreesia Inc is a healthcare technology company that provides patient intake and engagement solutions for healthcare organizations. The company’s solutions include PhreesiaPad, PhreesiaPlatform, PhreesiaPulse, and PhreesiaEHR Integration. Phreesia’s products are used by over 25,000 healthcare providers in the United States.
Phreesia has a market capitalization of $1.36 billion and a return on equity of -30.7%. The company’s products are used by healthcare providers to improve patient engagement and reduce administrative costs.
– Sharecare Inc ($NASDAQ:SHCR)
Sharecare is a social media platform that allows users to connect with others who have similar health concerns. The company also provides health information and resources. Sharecare’s market cap is 662.5M as of 2022. The company allows users to share their health journey, connect with others, and access health information and resources.
Summary
OptimizerX Corporation has seen a decrease in total revenue for the quarter ending June 30 2023, amounting to a 1.1% drop compared to the same period in FY2022. Net income for the period was negative 4.2 million, slightly worse than the negative 3.9 million reported the previous year. As such, investors should take caution when considering investing in OptimizerX Corporation due to the weak financial performance and bearish outlook on revenue growth. A thorough analysis of the company’s balance sheet and cash flow statement should be conducted to determine whether an investment in OptimizerX Corporation is prudent.
Related Posts
Recent Posts
